James N. Butera

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma

Jorge J. Castillo, Eric S. Winer, Dariusz Stachurski et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2010 · 200 citations

Prognostic Factors in Chemotherapy-Treated Patients with HIV-Associated Plasmablastic Lymphoma

Jorge J. Castillo, Eric S. Winer, Dariusz Stachurski et al. · The Oncologist · 2010 · 142 citations · Full text

EBV‐positive diffuse large B‐cell lymphoma of the elderly: A case series from Peru

Brady Beltrán, Jorge J. Castillo, Domingo Morales et al. · American Journal of Hematology · 2011 · 72 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Ebv-positive Dlbcl +14

A multiinstitutional, concurrent chemoradiation trial of strontium‐89, estramustine, and vinblastine for hormone refractory prostate carcinoma involving bone

Wallace Akerley, James N. Butera, Terek Wehbe et al. · Cancer · 2002 · 67 citations · Full text

Prognosis in primary effusion lymphoma is associated with the number of body cavities involved

Jorge J. Castillo, Helen Shum, Majid Lahijani et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2012 · 62 citations

Lymphoid Neoplasia, Surgical Oncology, Primary Effusion Lymphoma +13